Minerva reports 5.3% InfuSystem (INFU) stake in Schedule 13G/A
Rhea-AI Filing Summary
Minerva Advisors LLC and related entities report owning 1,078,731 shares of InfuSystem Holdings common stock, representing 5.3% of the company’s outstanding shares. The ownership is reported on a Schedule 13G/A as of 12/31/2025 and is based on 20,336,183 shares outstanding as of October 31, 2025.
The stake is held across Minerva Advisors LLC, Minerva Group, LP, Minerva GP, LP, Minerva GP, Inc., and David P. Cohen, with 764,517 shares held by Minerva Group, LP. The filers certify the securities are not held for the purpose of changing or influencing control, other than activities solely in connection with a nomination under Rule 14a-11.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stake in InfuSystem Holdings (INFU) does Minerva report on this Schedule 13G/A?
Minerva Advisors LLC and related entities report beneficial ownership of 1,078,731 InfuSystem common shares, equal to 5.3% of the outstanding stock, based on 20,336,183 shares outstanding as of October 31, 2025, as disclosed in InfuSystem’s Form 10-Q.
Which Minerva entities are listed as reporting persons for InfuSystem (INFU)?
The filing lists five reporting persons: Minerva Advisors LLC, Minerva Group, LP, Minerva GP, LP, Minerva GP, Inc., and individual David P. Cohen. Each is deemed a beneficial owner of 764,517 shares held by Minerva Group, LP, with Minerva Advisors and Cohen each reporting 1,078,731 shares.
How much of InfuSystem’s (INFU) stock does each Minerva entity beneficially own?
Minerva Advisors LLC and David P. Cohen each report beneficial ownership of 1,078,731 shares, or 5.3% of InfuSystem’s common stock. Minerva Group, LP, Minerva GP, LP, and Minerva GP, Inc. each report 764,517 shares, or 3.8% of the outstanding common stock, all tied to Minerva Group’s holdings.
Is Minerva’s InfuSystem (INFU) stake intended to change control of the company?
The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of InfuSystem. It notes an exception only for activities solely in connection with a nomination under Rule 240.14a-11, consistent with a passive investment filing on Schedule 13G.